Suppr超能文献

艰难梭菌感染:管理方面的最新进展

Clostridium difficile infection: Updates in management.

作者信息

Tariq Raseen, Khanna Sahil

机构信息

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.

出版信息

Indian J Gastroenterol. 2017 Jan;36(1):3-10. doi: 10.1007/s12664-016-0719-z. Epub 2016 Dec 20.

Abstract

Clostridium difficile was first identified in 1978 as a diarrhea-causing bacterium in humans. In the last three decades, C. difficile infection (CDI) has reached an epidemic state, both in health care and community settings worldwide. There has been substantial progress in the field of CDI, including identification of novel risk factors, presence of CDI in individuals not considered at risk previously, and treatment options including new drugs, monoclonal antibodies, and fecal microbiota transplantation. This review discusses epidemiology, novel and traditional risk factors, and updates in management for CDI.

摘要

艰难梭菌于1978年首次被鉴定为可导致人类腹泻的细菌。在过去三十年中,艰难梭菌感染(CDI)在全球范围内的医疗保健机构和社区环境中均已达到流行状态。CDI领域已取得了重大进展,包括识别新的风险因素、在以前未被视为有风险的个体中发现CDI,以及包括新药、单克隆抗体和粪便微生物群移植在内的治疗选择。本综述讨论了CDI的流行病学、新的和传统的风险因素以及管理方面的最新进展。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验